Only 0.01% of drug candidates entering clinical trials reach the market. With Charles River supporting >80% of drugs approved by the FDA over the last three years, improve your odds, leverage our experience, and expedite your time to market.

Our comprehensive portfolio supporting proteins, antibodies, vaccines, and cell and gene therapies includes:
• Cell and Gene Therapy CDMO Solutions
• Cell Bank and Virus Manufacturing
• Biophysical, Molecular, and Genetic Characterization Services
• Biosafety and Viral Clearance Studies
• Bioactivity and Potency Testing
• Stability and QC Testing

To learn how we can help to get your product to patients faster, visit www.criver.com/biologics-solutions.